Adam McCluskey and Phillip Robinson are embarking on an ambitious project that could radically change the way drug research is conducted in Australia. [ + ]

Agilent Technologies has announced a strategic partnership with Pacific Laboratory Products in Australia to provide best-in-class technical support and efficient delivery for the entire range of Agilent chromatography columns and supplies products.

Family of four had genome sequenced revealing intergenerational mutation rate and genes for Miller syndrome. [ + ]

Metastatic bowel cancer treatment, Erbitux, is one of the new generation of highly effective personalised medicine therapies. [ + ]

Datamonitor Group predicts antidiabetics market will continue to expand, but obesity plagued by perception and treatment issues. [ + ]

Brings Living Cell Technologies closer to commercialisation of xenotransplantation device to treat diabetes. [ + ]

Scientists at the Stanford University School of Medicine have devised a software algorithm that could enable a common laboratory device to virtually separate a whole-blood sample into its different cell types and detect medically important gene-activity changes specific to any one of those cell types.

A new test is available for the nervous necrosis virus - a serious disease affecting more than 35 species of fish worldwide. The new PCR method was first achieved through research and development funded by the Australian Research Council at the University of Sydney.

Researchers at the Garvan Institute of Medical Research found that individuals with Hepatitis C are more likely to develop diabetes. [ + ]

Strategic partnership will offer best-in-class support and efficient delivery of Agilent Columns and Supplies products. [ + ]

Protein in king cobra venom could lead to development of new therapeutics or molecular probes. [ + ]

CSL, ResMed, Primary Health Care [ + ]

Researchers from Australia and the US find that blood cells are derived from a number of stem cell subtypes. [ + ]

The sight of brown seaweed is not one that would normally have people seeing dollar signs, but for Hobart-based Marinova, its solvent-free technique for extracting the coveted element fucoidan from an introduced species of sea-flora in Tasmania has made it one of Australia’s most promising up and coming biotechs. [ + ]

The regulation of in vitro diagnostics in Australia will undergo significant change as pre-market regulatory approval and inclusion on the Australian Register of Therapeutic Goods is required for IVD devices under the new regulatory scheme, which comes into force on 1 July 2010.